Journal
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 36, Issue 2, Pages 225-235Publisher
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0035-1546752
Keywords
cystic fibrosis; non-CF bronchiectasis; microbiology; emerging pathogens; microbiome
Categories
Ask authors/readers for more resources
Chronic pulmonary sepsis is the predominant cause of morbidity for patients with cystic fibrosis (CF) and non-CF bronchiectasis. Previously it was thought that respiratory infection in these patients was mostly limited to a very small number of typical pathogens; however, in recent years there have been increasing reports of infection with other emerging potential pathogens including Burkholderia, Stenotrophomonas, Achromobacter, Ralstonia, Pandoraea, nontuberculous mycobacteria, and fungal species. Furthermore, culture-independent methodologies have established that the lungs of patients with CF and non-CF bronchiectasis comprise mixed microbiological communities of aerobic and anaerobic bacteria, fungal and viral species, collectively referred to as the lung microbiome. This article addresses the clinical relevance of emerging pathogens and the lung microbiome in CF and non-CF bronchiectasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available